Probiotic Lactobacillus rhamnosus inhibits the formation of neutrophil extracellular traps

Journal of Immunology

Volumn 192, Issue 4, 2014, Pages 1870-1877

  Vong, Linda ^a   Lorentz, Robert J ^a   Assa, Amit ^a   Glogauer, Michael ^b   Sherman, Philip M ^a,b  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; EXTRACELLULAR MATRIX; HL-60 CELLS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTESTINES; LACTOBACILLUS RHAMNOSUS; MICE; MICE, INBRED C57BL; NEUTROPHILS; PHAGOCYTOSIS; PROBIOTICS; REACTIVE OXYGEN SPECIES; STAPHYLOCOCCUS AUREUS; TETRADECANOYLPHORBOL ACETATE;

EID: 84894266945     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302286     Document Type: Article

References (45)

1. Amulic, B., C. Cazalet, G. L. Hayes, K. D. Metzler, and A. Zychlinsky. 2012. Neutrophil function: from mechanisms to disease. Annu. Rev. Immunol. 30: 459-489.
2. Nathan, C. 2006. Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 6: 173-182.
3. Brinkmann, V., U. Reichard, C. Goosmann, B. Fauler, Y. Uhlemann, D. S. Weiss, Y. Weinrauch, and A. Zychlinsky. 2004. Neutrophil extracellular traps kill bacteria. Science 303: 1532-1535.
4. Clark, S. R., A. C. Ma, S. A. Tavener, B. McDonald, Z. Goodarzi, M. M. Kelly, K. D. Patel, S. Chakrabarti, E. McAvoy, G. D. Sinclair, et al. 2007. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med. 13: 463-469.
5. McDonald, B., R. Urrutia, B. G. Yipp, C. N. Jenne, and P. Kubes. 2012. Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis. Cell Host Microbe 12: 324-333.
6. Yipp, B. G., B. Petri, D. Salina, C. N. Jenne, B. N. Scott, L. D. Zbytnuik, K. Pittman, M. Asaduzzaman, K. Wu, H. C. Meijndert, et al. 2012. Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo. Nat. Med. 18: 1386-1393.
7. Bianchi, M., A. Hakkim, V. Brinkmann, U. Siler, R. A. Seger, A. Zychlinsky, and J. Reichenbach. 2009. Restoration of NET formation by gene therapy in CGD controls aspergillosis. Blood 114: 2619-2622.
8. Fuchs, T. A., U. Abed, C. Goosmann, R. Hurwitz, I. Schulze, V. Wahn, Y. Weinrauch, V. Brinkmann, and A. Zychlinsky. 2007. Novel cell death program leads to neutrophil extracellular traps. J. Cell Biol. 176: 231-241.
9. Hakkim, A., B. G. Fürnrohr, K. Amann, B. Laube, U. A. Abed, V. Brinkmann, M. Herrmann, R. E. Voll, and A. Zychlinsky. 2010. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc. Natl. Acad. Sci. USA 107: 9813-9818.
10. Kessenbrock, K., M. Krumbholz, U. Schönermarck, W. Back, W. L. Gross, Z. Werb, H. J. Gröne, V. Brinkmann, and D. E. Jenne. 2009. Netting neutrophils in autoimmune small-vessel vasculitis. Nat. Med. 15: 623-625.
11. Papayannopoulos, V., D. Staab, and A. Zychlinsky. 2011. Neutrophil elastase enhances sputum solubilization in cystic fibrosis patients receiving DNase therapy. PLoS One 6: e28526.
12. Honda, K., and K. Takeda. 2009. Regulatory mechanisms of immune responses to intestinal bacteria. Mucosal Immunol. 2: 187-196.
13. Frank, D. N., A. L. St Amand, R. A. Feldman, E. C. Boedeker, N. Harpaz, and N. R. Pace. 2007. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. USA 104: 13780-13785.
14. Huynh, H. Q., J. deBruyn, L. Guan, H. Diaz, M. Li, S. Girgis, J. Turner, R. Fedorak, and K. Madsen. 2009. Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: a pilot study. Inflamm. Bowel Dis. 15: 760-768.
15. Miele, E., F. Pascarella, E. Giannetti, L. Quaglietta, R. N. Baldassano, and A. Staiano. 2009. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am. J. Gastroenterol. 104: 437-443.
16. Downard, C. D., E. Renaud, S. D. St Peter, F. Abdullah, S. Islam, J. M. Saito, M. L. Blakely, E. Y. Huang, M. J. Arca, L. Cassidy, and G. Aspelund; 2012 American Pediatric Surgical Association Outcomes Clinical Trials Committee. 2012. Treatment of necrotizing enterocolitis: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. J. Pediatr. Surg. 47: 2111-2122.
17. Gareau, M. G., P. M. Sherman, and W. A. Walker. 2010. Probiotics and the gut microbiota in intestinal health and disease. Nat. Rev. Gastroenterol. Hepatol. 7: 503-514.
18. Karmali, M. A., M. Mascarenhas, S. Shen, K. Ziebell, S. Johnson, R. Reid-Smith, J. Isaac-Renton, C. Clark, K. Rahn, and J. B. Kaper. 2003. Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxinproducing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease. J. Clin. Microbiol. 41: 4930-4940.
19. Philpott, D. J., D. M. McKay, W. Mak, M. H. Perdue, and P. M. Sherman. 1998. Signal transduction pathways involved in enterohemorrhagic Escherichia coliinduced alterations in T84 epithelial permeability. Infect. Immun. 66: 1680-1687.
20. Sweeney, N. J., D. C. Laux, and P. S. Cohen. 1996. Escherichia coli F-18 and E. coli K-12 eda mutants do not colonize the streptomycin-treated mouse large intestine. Infect. Immun. 64: 3504-3511.
21. Clark, E. C., S. D. Patel, P. R. Chadwick, G. Warhurst, A. Curry, and G. L. Carlson. 2003. Glutamine deprivation facilitates tumour necrosis factor induced bacterial translocation in Caco-2 cells by depletion of enterocyte fuel substrate. Gut 52: 224-230.
22. Darfeuille-Michaud, A., J. Boudeau, P. Bulois, C. Neut, A. L. Glasser, N. Barnich, M. A. Bringer, A. Swidsinski, L. Beaugerie, and J. F. Colombel. 2004. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127: 412-421.
23. Lim, M. B., J. W. Kuiper, A. Katchky, H. Goldberg, and M. Glogauer. 2011. Rac2 is required for the formation of neutrophil extracellular traps. J. Leukoc. Biol. 90: 771-776.
24. Pilsczek, F. H., D. Salina, K. K. Poon, C. Fahey, B. G. Yipp, C. D. Sibley, S. M. Robbins, F. H. Green, M. G. Surette, M. Sugai, et al. 2010. A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to Staphylococcus aureus. J. Immunol. 185: 7413-7425.
25. Savchenko, A. S., A. Inoue, R. Ohashi, S. Jiang, G. Hasegawa, T. Tanaka, T. Hamakubo, T. Kodama, Y. Aoyagi, T. Ushiki, and M. Naito. 2011. Long pentraxin 3 (PTX3) expression and release by neutrophils in vitro and in ulcerative colitis. Pathol. Int. 61: 290-297.
26. Moorthy, G., M. R. Murali, and S. N. Devaraj. 2007. Protective role of lactobacilli in Shigella dysenteriae 1-induced diarrhea in rats. Nutrition 23: 424-433.
27. Nixon, A. F., S. J. Cunningham, H. W. Cohen, and E. F. Crain. 2012. The effect of Lactobacillus GG on acute diarrheal illness in the pediatric emergency department. Pediatr. Emerg. Care 28: 1048-1051.
28. Duerr, R. H., S. R. Targan, C. J. Landers, L. R. Sutherland, and F. Shanahan. 1991. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Gastroenterology 100: 1590-1596.
29. Malíčková, K., D. Duricová, M. Bortlík, Z. Hrušková, B. Svobodová, N. Machková, V. Komárek, T. Fučíková, I. Janatková, T. Zima, and M. Lukáš. 2011. Impaired deoxyribonuclease I activity in patients with inflammatory bowel diseases. Autoimmune Dis. 2011: 945861.
30. Hessle, C., B. Andersson, and A. E. Wold. 2000. Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production. Infect. Immun. 68: 3581-3586.
31. Lee, I. C., S. Tomita, M. Kleerebezem, and P. A. Bron. 2013. The quest for probiotic effector molecules - unraveling strain specificity at the molecular level. Pharmacol. Res. 69: 61-74.
32. Meijerink, M., J. M. Wells, N. Taverne, M. L. de Zeeuw Brouwer, B. Hilhorst, K. Venema, and J. van Bilsen. 2012. Immunomodulatory effects of potential probiotics in a mouse peanut sensitization model. FEMS Immunol. Med. Microbiol. 65: 488-496.
33. Dong, H., I. Rowland, and P. Yaqoob. 2012. Comparative effects of six probiotic strains on immune function in vitro. Br. J. Nutr. 108: 459-470.
34. Marin-Esteban, V., I. Turbica, G. Dufour, N. Semiramoth, A. Gleizes, R. Gorges, I. Beau, A. L. Servin, V. Lievin-Le Moal, C. Sandré, and S. Chollet-Martin. 2012. Afa/Dr diffusely adhering Escherichia coli strain C1845 induces neutrophil extracellular traps that kill bacteria and damage human enterocyte-like cells. Infect. Immun. 80: 1891-1899.
35. Zigra, P. I., V. E. Maipa, and Y. P. Alamanos. 2007. Probiotics and remission of ulcerative colitis: a systematic review. Neth. J. Med. 65: 411-418.
36. Hafez, M., K. Hayes, M. Goldrick, R. K. Grencis, and I. S. Roberts. 2010. The K5 capsule of Escherichia coli strain Nissle 1917 is important in stimulating expression of Toll-like receptor 5, CD14, MyD88, and TRIF together with the induction of interleukin-8 expression via the mitogen-activated protein kinase pathway in epithelial cells. Infect. Immun. 78: 2153-2162.
37. Savijoki, K., N. Lietzén, M. Kankainen, T. Alatossava, K. Koskenniemi, P. Varmanen, and T. A. Nyman. 2011. Comparative proteome cataloging of Lactobacillus rhamnosus strains GG and Lc705. J. Proteome Res. 10: 3460-3473.
38. Yan, F., H. Cao, T. L. Cover, R. Whitehead, M. K. Washington, and D. B. Polk. 2007. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132: 562-575.
39. Seth, A., F. Yan, D. B. Polk, and R. K. Rao. 2008. Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism. Am. J. Physiol. Gastrointest. Liver Physiol. 294: G1060-G1069.
40. Yan, F., H. Cao, T. L. Cover, M. K. Washington, Y. Shi, L. Liu, R. Chaturvedi, R. M. Peek, Jr., K. T. Wilson, and D. B. Polk. 2011. Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J. Clin. Invest. 121: 2242-2253.
41. Tompkins, T. A., G. Barreau, and V. G. de Carvalho. 2012. Draft genome sequence of probiotic strain Lactobacillus rhamnosus R0011. J. Bacteriol. 194: 902.
42. Brinkmann, V., and A. Zychlinsky. 2012. Neutrophil extracellular traps: is immunity the second function of chromatin? J. Cell Biol. 198: 773-783.
43. Ciorba, M. A., T. E. Riehl, M. S. Rao, C. Moon, X. Ee, G. M. Nava, M. R. Walker, J. M. Marinshaw, T. S. Stappenbeck, and W. F. Stenson. 2012. Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2-dependent manner. Gut 61: 829-838.
44. Goyal, N., P. Rishi, and G. Shukla. 2013. Lactobacillus rhamnosus GG antagonizes Giardia intestinalis induced oxidative stress and intestinal disaccharidases: an experimental study. World J. Microbiol. Biotechnol. 29: 1049-1057.
45. Gan, B. S., J. Kim, G. Reid, P. Cadieux, and J. C. Howard. 2002. Lactobacillus fermentum RC-14 inhibits Staphylococcus aureus infection of surgical implants in rats. J. Infect. Dis. 185: 1369-1372.